SEC Company Response from Microbot Medical Inc. (MBOT) (CIK 0000883975) (MBOT) — Apr 12, 2017
Microbot Medical Inc. (MBOT) (CIK 0000883975)
Date: April 12, 2017 · CIK: 0000883975 · Accession: 0001493152-17-003775
AI Filing Summary & Sentiment
File numbers found in text: 333-217076
Letter
MICROBOT MEDICAL INC.
Recreation Park Drive, Unit 108
Hingham, MA 02043
April 12, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
F Street, N.E.
Washington, D.C. 20549
Re: Microbot Medical Inc.
Registration Statement on Form S-3
File No. 333-217076
Request for Acceleration
Ladies and Gentlemen:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Microbot Medical Inc. (the “Company”), that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of its Registration Statement to Friday, April 14, 2017, at 4:00 p.m. Eastern Time, or as soon thereafter as practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call Marc Mantell or Flora Brookfield of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (617) 542-6000, with any comments or questions regarding the Registration Statement.
Very
truly yours,
Microbot
Medical Inc.
Show Raw Text
CORRESP
1
filename1.htm
MICROBOT
MEDICAL INC.
25
Recreation Park Drive, Unit 108
Hingham,
MA 02043
April
12, 2017
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporate Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Microbot
Medical Inc.
Registration
Statement on Form S-3
File
No. 333-217076
Request
for Acceleration
Ladies
and Gentlemen:
With
respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and pursuant to
Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests,
on behalf of Microbot Medical Inc. (the “Company”), that the Securities and Exchange Commission (the “Commission”)
accelerate the effective date of its Registration Statement to Friday, April 14, 2017, at 4:00 p.m. Eastern Time, or as soon thereafter
as practicable.
The
cooperation of the staff in meeting the timetable described above is very much appreciated.
Please
call Marc Mantell or Flora Brookfield of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (617)
542-6000, with any comments or questions regarding the Registration Statement.
Very
truly yours,
Microbot
Medical Inc.
By:
/s/
Harel Gadot
Harel
Gadot
Chairman,
President and Chief Executive Officer
cc:
Suzanne
Hayes, Securities and Exchange Commission
Christine
Westbrook, Securities and Exchange Commission
Marc
D. Mantell, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Stephen
E. Fox, Esq., Ruskin Moscou Faltischek, P.C.